myExtraContent1
myExtraContent5

Mar 2012

6th Scientific Symposium on the occasion of World Tuberculosis Day 2012

VPM is going to present on „Development of VPM1002, a novel rBCG vaccine to replace current BCG“ at the 6th Scientific Symposium on the occasion of World Tuberculosis Day 2012 in Berlin on March 20-21, 2012.

VPM at Symposium - Fighting the Scourge of TB/HIV Co-Infection, Are Vaccines and Novel Diagnostics the Solution?

VPM is going to present on „Vaccine designing in TB - Challenges and hopes“ at the symposium FIGHTING THE SCOURGE OF TB/HIV CO-INFECTION, ARE VACCINES AND NOVEL DIAGNOSTICS THE SOLUTION? in Munich on March 3, 2012.

TRANSVAC CALLS FOR NEW PARTNERS AND FREE SERVICES IN VACCINE DEVELOPMENT

TRANSVAC is a collaborative infrastructure project funded under the European Commission’s (EC) 7th Framework Programme (FP7). The project is the joint effort of leading European groups in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC was designed in order to enhance European research and training and foster the seamless implementation of a permanent research infrastructure for early vaccine development in Europe.
In order to sustain vaccine research infrastructure in Europe, the TRANSVAC consortium will consider the integration of new partners into the TRANSVAC infrastructure, mainly when they can offer services which are not covered by the current work plan.
The services provided by the potential new partners will be integrated in the advertising plan and the transnational access call in order for the potential new partners to extend their network and make their services available on a paid basis to the scientific community.
myExtraContent7
myExtraContent8